Search results
Body Surface Electrocardiographic Mapping for Non-invasive Identification of Arrhythmic Sources
Author(s):
Ashok J Shah
,
Meleze Hocini
,
Patrizio Pascale
,
et al
Added:
3 years ago
Article
Phillip Cuculich
Author
Author(s):
Phillip Cuculich
,
Pier D Lambiase
,
David Calvo Cuervo
Start date:
Jan 09, 2019
View more
Author(s):
Eun-Jeong Kim
,
Giovanni Davogustto
,
William G Stevenson
,
et al
Added:
3 years ago
Myocardial scars from infarction or replacement fibrosis in non-ischaemic cardiomyopathies are the common substrate for sustained monomorphic ventricular tachycardia (VT).1,2 In selected patients at high risk of ventricular arrhythmias, placement of an implantable cardioverter-defibrillator (ICD) is effective for prevention of sudden cardiac death.2 Although ICDs are effective in terminating VT…
View more
Author(s):
Seigo Yamashita
,
Ashok J Shah
,
Saagar Mahida
,
et al
Added:
3 years ago
Catheter ablation therapy has been widely used for rhythm control in patients with atrial fibrillation(AF).1 Since the first report in 1994,2 several interventional techniques have been proposed for AF, including replication of the surgical Maze,2 targeting pulmonary vein (PV) foci,3 segmental ostial and circumferential PV isolation,4,5 ganglionated plexi ablation,6 linear lesions in the left…
View more
Author(s):
Adam J Graham
,
Michele Orini
,
Pier D Lambiase
Added:
3 years ago
Recurrent episodes of ventricular tachycardia (VT) in patients with structural heart disease are associated with increased mortality and morbidity, despite the life-saving benefits of implantable cardiac defibrillators (ICDs).1,2 Because ICD therapies are abortive and do not alter the underlying arrhythmogenic substrate, their reduction becomes important, especially as recurrent shocks can cause…
View more
Author(s):
Saagar Mahida
,
Benjamin Berte
,
Seigo Yamashita
,
et al
Added:
3 years ago
Since the first catheter ablation for cardiac arrhythmia more than three decades ago, ablation technology has continually evolved at a rapid pace. Much of the early progress in the field was made in ablation of supraventricular tachycardias. Following a seminal study from Haïssaguerre et al.1 in 1998, which demonstrated that pulmonary vein triggers are important sources of atrial fibrillation (AF…
View more
Author(s):
Rahul K Mukherjee
,
Steven E Williams
,
Steve Niederer
,
et al
Added:
3 years ago
AF is the most common cardiac arrhythmia of clinical significance with an estimated prevalence of >33 million individuals globally.1 AF can be associated with significant symptoms and impaired quality of life of affected patients while also increasing the risk of stroke, heart failure and death.2 AF frequently co-exists with heart failure (HF). Up to half of patients with HF in the Framingham…
View more
Author(s):
George Thomas
,
Jiwon Kim
,
Bruce B Lerman
Added:
3 years ago
CRT is an essential treatment for patients with heart failure and reduced ejection fraction as it can restore left ventricular (LV) electrical and mechanical synchrony. It has been shown to increase quality of life, improve functional status, reduce hospitalisation, improve LV systolic function and reduce mortality in properly selected patients.1,2 While CRT is an effective therapy, approximately…
View more
Author(s):
Shohreh Honarbakhsh
,
Rui Providencia
,
Pier D Lambiase
Added:
3 years ago
Brugada syndrome (BrS) remains one of the most common inherited channelopathies associated with an increased risk of sudden cardiac death (SCD), with a worldwide prevalence of approximately 0.05%.1–3 It is accepted that appropriate utilisation of the ICD in high-risk patients with aborted SCD and haemodynamically compromising arrhythmias is life-saving. However, there remains a lack of consensus…
View more